Gabapentin Tablet, Film Coated
Product Images NDC 70010-228

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 70010-228). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Equation (Equation)

A formula illustrating the calculation for creatinine clearance (CLCr), including variables such as age, weight, serum creatinine, and a gender adjustment factor for female patients.*

FDA Label Image

Fig-1 (Fig 1)

A line graph showing mean pain scores over an 8-week period comparing placebo and Gabapentin 3600 mg/day. The x-axis represents weeks from baseline to week 8, while the y-axis shows mean pain scores from 0 to 10. The 4-week dose titration and 4-week fixed dose periods are indicated.*

FDA Label Image

Fig-2 (Fig 2)

A line graph depicting mean pain scores over seven weeks comparing placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The horizontal axis shows time in weeks with a 3-week dose titration period followed by a 4-week fixed dose period. The vertical axis shows mean pain scores from 0 to 10.*

FDA Label Image

Fig-3 (Fig 3)

A bar chart titled "Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies" showing results from two studies. It compares proportions of responders for placebo (PBO) and gabapentin (GBP) at dosages 1800 mg, 2400 mg, and 3600 mg. The chart highlights statistically significant differences with p-values less than 0.01 and 0.001.*

FDA Label Image

Fig-4 (Fig 4)

A scatter plot chart showing the difference percentage on the y-axis versus daily dose in mg on the x-axis, with data points representing three studies labeled as Study a, Study b, and Study c. The chart includes doses ranging approximately from 600 mg to 1800 mg.*

FDA Label Image

Image Description (Gaba Tab 70010 227 01)

Label for Gabapentin Tablets, USP, 600 mg, film-coated tablets in a package of 100. Label shows active ingredient Gabapentin, manufactured by Granules India Limited and Granules Pharmaceuticals Inc. Storage instructions, dosage advisory, and barcode are also visible.*

FDA Label Image

Image Description (Gaba Tab 70010 228 01)

Gabapentin Tablets, USP 800 mg film-coated oral tablets label. The package contains 100 tablets, labeled for prescription use only. Manufactured by Granules India Limited, Hyderabad, India, and distributed by Granules Pharmaceuticals Inc., Chantilly, VA. The label includes storage instructions, medication guide information, and barcodes.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Gabapentin, showing a cyclohexane ring with amino and carboxyl functional groups attached, representing the molecular structure of the active ingredient Gabapentin.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.